Please see below for a list of search results.
This business plan sets out our ambitions for 2018/19. The HTA operates a continuous business planning process - we maintain a pipeline of proposed business activities over a three-year period, which allows us to adapt and plan in response to changes in our operating environment.
Our strategy was developed following a fundamental evaluation of the extent to which our current strategic approach protects public and professional confidence in the proper use, and quality and safety, of human tissues, cells and organs.
During 2017, the HTA undertook a fundamental review of its strategy. This exercise gave us considerable reassurance that the public and professionals think we are on the right track with our regulatory approach.
The HTA is an executive Non-Departmental Public Body sponsored by the Department of Health and Social Care, established by the Human Tissue Act 2004.
The Regulations transposing EU import and coding Directives came into force on 1 April 2018. Changes to these Regulations affect all licensed establishments in the human application sector.